Tilray Brands Proposes Reverse Split Of Up To 20-To-1 To Regain Nasdaq Compliance

Tilray Brands (TSX: TLRY) is seeking shareholder approval to conduct a reverse stock split in an effort to regain compliance with Nasdaq minimum listing standards.

The company is proposing a reverse stock split that would occur at a ratio ranging from 10-to-1 to 20-to-1, with the board of directors to ultimately select where within this range the split would fall once shareholder approval is granted. A special meeting of shareholders is planned for June 10, 2025 to vote on the matter.

“The Reverse Stock Split will better align Tilray’s number of shares outstanding with companies of our size and scope. A higher price per share would ensure compliance with Nasdaq’s continued listing requirements and places Tilray in a position to continue executing on our strategic plans,” commented Irwin Simon, CEO of Tilray.

The company has also claimed that conducting the reverse split would decrease the cost structure of Tilray by up to $1.0 million on an annual run rate basis, however it is unclear how this would be achieved.

Tilray at the present time has an estimated 937.66 million shares outstanding.

Tilray Brands last traded at $0.66 on the TSX.


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from...

Thursday, October 24, 2019, 09:15:29 AM

Aphria, Tilray Granted Regulatory Clearance Under Competition Act For Combination

Aphria Inc (TSX: APHA) (NASDAQ: APHA) this evening reported that the transaction with that of...

Tuesday, February 23, 2021, 04:27:22 PM

Tilray Brands Q3 Earnings Analysis: Behind The CEO’s “Robust” Claims

“Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning...

Saturday, April 12, 2025, 03:28:00 PM

Tilray Q2 Earnings: What’s the Plan Here?

Another quarter, and another loss for Tilray Brands (TSX: TLRY) shareholders who are left wondering...

Sunday, January 19, 2025, 11:28:00 AM

Tilray Sees Jefferies Lower Target Due To Canadian Cannabis Headwinds

Jefferies lowered their price target on Tilray Brands (TSX: TLRY), after updating their outlook, saying...

Sunday, April 10, 2022, 01:03:00 PM